CARD9 and cancer: Notably, OTUD1 has been implicated in modulating antifungal innate immunity through the deubiquitination of CARD9 [25], while its deficiency in various human cancers is strongly linked to cell survival, apoptosis [26,27], and the inhibition of cancer progression by triggering immunogenic cell death [28,29].